Rivaroxaban Vascular Zentiva 2,5 mg, Filmtabletten - 196 Swissmedic Key 68749004 Registration Holder Helvepharm AG Name Rivaroxaban Vascular Zentiva 2,5 mg, Filmtabletten Date of registration 20.06.2024 Introduction of Sequence 20.06.2024 ATC-Classification Rivaroxaban (B01AF01) Revision date WHO WHO-DDD Valid until 19.06.2029 Index Therapeuticus (BSV) Show package size 196 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680687490047 Medication Code Synthetika Pharmacode Disponibility
Composition rivaroxabanum 2.5 mg, lactosum monohydricum 28.50 mg, carmellosum natricum conexum, hypromellosum, cellulosum microcristallinum, natrii laurilsulfas, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, macrogolum 3350, E 172 (flavum), pro compresso obducto corresp. natrium 0.44 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Rivaroxabanum 2.5 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 172 color. Hypromellosum Überzug Lactose Monohydrate 28.5 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Pro Compresso Obducto Titanium Dioxide
Source Data was imported : 04.07.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
